Emergent BioSolutions EBS
NYSE EBS
$6.18 -0.18 (-2.91%)
As of: Oct 20, 2026 · 11:16 AM EDT

Emergent BioSolutions (EBS) Other Investing Activities (2023 - 2025)

Updated

Analysis

Emergent BioSolutions (EBS) Other Investing Activities (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,156.21 Bn 1,124.80 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 624.61 Bn 543.14 Bn 17.26 Bn 407.00 Mn
3 AbbVie 510.48 Bn 483.59 Bn 12.70 Bn -51.00 Mn
4 Merck 365.61 Bn 319.99 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 296.78 Bn 260.77 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 261.28 Bn 234.97 Bn 12.86 Bn 174.00 Mn
7 Amgen 234.72 Bn 190.12 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 193.73 Bn 167.93 Bn 6.22 Bn 20.00 Mn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn -1.00 Mn
10 Emergent BioSolutions 318.37 Mn -432.53 Mn 137.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -5.00 Mn
Dec 31, 2023 6.30 Mn
API Access

Emergent BioSolutions Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=EBS&period=max&api_key=YOUR_API_KEY